Microorganisms and methods for the biosynthesis of butadiene
US-9732361-B2 · Aug 15, 2017 · US
US10487343B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10487343-B2 |
| Application number | US-201715645880-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 10, 2017 |
| Priority date | May 5, 2010 |
| Publication date | Nov 26, 2019 |
| Grant date | Nov 26, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides non-naturally occurring microbial organisms having a butadiene pathway. The invention additionally provides methods of using such organisms to produce butadiene.
Opening claim text (preview).
What is claimed is: 1. A non-naturally occurring microbial organism comprising a biosynthetic pathway for the production of crotyl alcohol wherein said biosynthetic pathway comprises at least one exogenous nucleic acid encoding at least one metabolic pathway enzyme expressed in a sufficient amount to produce crotyl alcohol, wherein said biosynthetic pathway comprises converting crotonyl-CoA to crotyl alcohol using one or more metabolic pathway enzymes, wherein said metabolic pathway enzymes are selected from the group consisting of: (i) a crotonyl-CoA reductase converting crotonyl-CoA to crotonaldehyde, and a crotonaldehyde reductase converting crotonaldehyde to crotyl alcohol; (ii) a crotonyl-CoA reductase converting crotonyl-CoA to crotyl alcohol; and (iii) a crotonyl-CoA hydrolase, a crotonyl-CoA synthetase, or a crotonyl-CoA transferase converting crotonyl-CoA to crotonate, a crotonate reductase converting crotonate to crotonaldehyde, and a crotonaldehyde reductase converting crotonaldehyde to crotyl alcohol, and wherein said biosynthetic pathway further comprises: (i) converting acetyl-CoA to crotonyl-CoA using an acetyl-CoA:acetyl-CoA acyltransferase, an acetoacetyl-CoA reductase and a 3-hydroxybutyryl-CoA dehydratase; (ii) converting glutaconyl-CoA to crotonyl-CoA using a glutaconyl-CoA decarboxylase; (iii) converting glutaryl-CoA to crotonyl-CoA using a glutaryl-CoA dehydrogenase; (iv) converting 3-aminobutyryl-CoA to crotonyl-CoA using an 3-aminobutyryl-CoA deaminase; or (v) converting 4-hydroxybutyryl-CoA to crotonyl-CoA using a 4-hydroxybutyryl-CoA dehydratase. 2. The non-naturally occurring microbial organism of claim 1 , wherein said microbial organism comprises one exogenous nucleic acid encoding a metabolic pathway enzyme. 3. The non-naturally occurring microbial organism of claim 1 , wherein said biosynthetic pathway comprises a crotonyl-CoA reductase converting crotonyl-CoA to crotonaldehyde and a crotonaldehyde reductase converting crotonaldehyde to crotyl alcohol. 4. The non-naturally occurring microbial organism of claim 3 , wherein said biosynthetic pathway further comprises converting acetyl-CoA to crotonyl-CoA using an acetyl-CoA:acetyl-CoA acyltransferase, an acetoacetyl-CoA reductase and a 3-hydroxybutyryl-CoA dehydratase. 5. The non-naturally occurring microbial organism of claim 3 , wherein said biosynthetic pathway further comprises converting glutaconyl-CoA to crotonyl-CoA using a glutaconyl-CoA decarboxylase. 6. The non-naturally occurring microbial organism of claim 3 , wherein said biosynthetic pathway further comprises converting glutaryl-CoA to crotonyl-CoA using a glutaryl-CoA dehydrogenase. 7. The non-naturally occurring microbial organism of claim 3 , wherein said biosynthetic pathway further comprises converting 3-aminobutyryl-CoA to crotonyl-CoA using an 3-aminobutyryl-CoA deaminase. 8. The non-naturally occurring microbial organism of claim 3 , wherein said biosynthetic pathway further comprises converting 4-hydroxybutyryl-CoA to crotonyl-CoA using a 4-hydroxybutyryl-CoA dehydratase. 9. The non-naturally occurring microbial organism of claim 1 , wherein said biosynthetic pathway comprises a crotonyl-CoA reductase converting crotonaldehyde to crotyl alcohol. 10. The non-naturally occurring microbial organism of claim 9 , wherein said biosynthetic pathway further comprises converting acetyl-CoA to crotonyl-CoA using an acetyl-CoA:acetyl-CoA acyltransferase, an acetoacetyl-CoA reductase and a 3-hydroxybutyryl-CoA dehydratase. 11. The non-naturally occurring microbial organism of claim 9 , wherein said biosynthetic pathway further comprises converting glutaconyl-CoA to crotonyl-CoA using a glutaconyl-CoA decarboxylase. 12. The non-naturally occurring microbial organism of claim 9 , wherein said biosynthetic pathway further comprises converting glutaryl-CoA to crotonyl-CoA using a glutaryl-CoA dehydrogenase. 13. The non-naturally occurring microbial organism of claim 9 , wherein said biosynthetic pathway further comprises converting 3-aminobutyryl-CoA to crotonyl-CoA using an 3-aminobutyryl-CoA deaminase. 14. The non-naturally occurring microbial organism of claim 9 , wherein said biosynthetic pathway further comprises converting 4-hydroxybutyryl-CoA to crotonyl-CoA using a 4-hydroxybutyryl-CoA dehydratase. 15. The non-naturally occurring microbial organism of claim 1 , said biosynthetic pathway comprises a crotonyl-CoA hydrolase, crotonyl-CoA synthetase or crotonyl-CoA transferase converting crotonyl-CoA to crotonate, a crotonate reductase converting crotonate to crotonaldehyde, and crotonaldehyde reductase converting crotonaldehyde to crotyl alcohol. 16. The non-naturally occurring microbial organism of claim 15 , wherein said biosynthetic pathway further comprises converting acetyl-CoA to crotonyl-CoA using an acetyl-CoA:acetyl-CoA acyltransferase, an acetoacetyl-CoA reductase and a 3-hydroxybutyryl-CoA dehydratase. 17. The non-naturally occurring microbial organism of claim 15 , wherein said biosynthetic pathway further comprises converting glutaconyl-CoA to crotonyl-CoA using a glutaconyl-CoA decarboxylase. 18. The non-naturally occurring microbial organism of claim 15 , wherein said biosynthetic pathway further comprises converting glutaryl-CoA to crotonyl-CoA using a glutaryl-CoA dehydrogenase. 19. The non-naturally occurring microbial organism of claim 15 , wherein said biosynthetic pathway further comprises converting 3-aminobutyryl-CoA to crotonyl-CoA using an 3-aminobutyryl-CoA deaminase. 20. The non-naturally occurring microbial organism of claim 15 , wherein said biosynthetic pathway further comprises converting 4-hydroxybutyryl-CoA to crotonyl-CoA using a 4-hydroxybutyryl-CoA dehydratase. 21. The non-naturally occurring microbial organism of claim 1 , wherein said at least one exogenous nucleic acid is a heterologous nucleic acid. 22. The non-naturally occurring microbial organism of claim 1 , wherein said non-naturally occurring microbial organism is in a substantially anaerobic culture medium. 23. The non-naturally occurring microbial organism of claim 1 , wherein said microbial organism is a bacteria, a yeast, or a fungus. 24. The non-naturally occurring microbial organism of claim 23 , wherein said bacteria is Escherichia coli. 25. A method for producing crotyl alcohol comprising culturing the non-naturally occurring microbial organism of claim 1 under conditions and for a sufficient period of time to produce crotyl alcohol. 26. The method of claim 25 , wherein said non-naturally occurring microbial organism is in a substantially anaerobic culture medium. 27. The method of claim 25 , wherein said method further comprises separating the butadiene from other components in the culture. 28. The method of claim 27 , wherein the separating comprises extraction, continuous liquid-liquid extraction, pervaporation, membrane filtration, membrane separation, reverse osmosis, distillation, centrifugation, extractive filtration, ion exchange chromatography, absorption chromatography, or ultrafiltration. 29. The non-naturally occurring microbial organism of claim 1 , wherein said microbial organism comprises two exogenous nucleic acids each encoding a metabolic pathway enzyme. 30. The non-naturally occurring microbial organism of claim 1 , wherein said microbial organism comp
acyclic · CPC title
Fungi (culture of mushrooms A01G18/00; as new plants A01H15/00); Culture media therefor · CPC title
Unsaturated compounds, i.e. alkenes, alkynes or allenes · CPC title
Genes encoding for enzymes or proenzymes · CPC title
Baker's yeast; Brewer's yeast · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.